Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs in rapidly progressive interstitial lung disease
NCT02594839Phase 2Completed
- Sponsor
- Federal Research Clinical Center of the FMBA
- Start
- Feb 2013
- Primary completion
- Jan 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mesenchymal stem cells in idiopathic interstitial pneumonia (IIP), interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), sponsored by Federal Research Clinical Center of the FMBA. Started Feb 2013; status: completed.
02
Drugs
bone marrow mesenchymal stem cells
03
Conditions
idiopathic interstitial pneumonia (IIP)interstitial lung disease (ILD)idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02594839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594839.